SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Valion Bio Advances Entolimod Into U.S.-Funded Efficacy Study

NIAID-RNCP selected Entolimod for a fully funded study evaluating efficacy against gastrointestinal acute radiation syndrome after positive safety findings.

VBIO

Related stories